This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
09/02/15 - 2:44:12 PM ET (BATS BZX Real-time Price)
Div Yield: --
PSTI Day's Range
PSTI 52 Week Range
PSTI Business Summary
Pluristem Therapeutics Inc., through its subsidiary, Pluristem Ltd., operates as a bio-therapeutics company in Israel.View PSTI key stats
Pluristem Therapeutics Inc - PSTI - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Pluristem Therapeutics Inc as a
Sell with a ratings score of D.
Report Snippet: We rate PLURISTEM THERAPEUTICS INC (PSTI) a SELL. This is driven by some concerns, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the stocks we cover. The company's weaknesses can be seen in multiple areas, such as its disappointing return on equity, weak operating cash flow and generally disappointing historical performance in the stock itself.